28.09. – 01.10.2026 | Discovery on target
Boston, MA / USA
29.09. – 01.10.2026 | BIO Spain
Bilbao / Spain
12.10. – 15.10.2026 | World ADC
San Diego, CA / USA
13.10. – 15.10.2026 | FOB EU
Basel / CH
04.11. – 08.11.2026 | SITC
Phoenix, Arizona / USA
09.11. – 11.11.2026 | BIO EU
Cologne / Germany
17.11. – 19.11.2026 | PEGS EU
Lisboa / Portugal
14.12. – 17.12.2026 | Antibody Engineering & Therapeutics
San Diego, CA / USA
YUMAB and ISAR Bioscience create platform for blood-brain-barrier drug delivery
YUMAB and ISAR Bioscience Collaborate to Develop a Novel Transferrin Receptor Antibody Platform for Delivering Therapeutics Across Blood-Brain Barrier. YUMAB GmbH (“YUMAB”), a leading antibody discovery contract research organization headquartered in Braunschweig, Germany, and ISAR Bioscience GmbH (“ISAR Bioscience”), a regenerative and translational medicine driven company based in Planegg, Germany, announced their collaboration to develop […]
Unlocking intracellular targets with highly specific TCR-like antibodies
Specificity is key to developing safe TCR or TCR-like antibody therapeutics. YUMAB’S novel CHO-display library presents the natural human pHLA repertoire on the cell surface, thereby enabling thorough counter-selections and screenings to identify TCRs or TCR-like antibodies with minimal off-target binding at early stages of drug discovery. This case study explains how our new TCRm […]